ROCKWELL MEDICAL, INC. Available-for-sale Securities, Gross Realized Losses
ROCKWELL MEDICAL, INC. (RMTI) reported Available-for-sale Securities, Gross Realized Losses of $4.42 thousand for the 3-month period ending 2018-03-31, per its 10-Q/A filed 2018-08-14.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses · last filed 2018-08-14
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized losses for the quarter ending 2018-03-31 was $4.42K.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized losses for the quarter ending 2017-09-30 was $199.76K.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized losses for the quarter ending 2017-06-30 was $473.87K.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized losses for fiscal 2016 was $26.82K, a 53.83% decline from fiscal 2015.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized losses for fiscal 2015 was $58.09K, a 4650.20% increase from fiscal 2014.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized losses for fiscal 2014 was $1.22K.
- ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized losses for fiscal 2012 was $67.30K, a 20.44% decline from fiscal 2011.
| Period end | Available-for-sale Securities, Gross Realized Losses 3 month | Available-for-sale Securities, Gross Realized Losses 6 month | Available-for-sale Securities, Gross Realized Losses 9 month | Available-for-sale Securities, Gross Realized Losses 12 month |
|---|---|---|---|---|
| 2018-03-31 | $4.42K 10-Q/A · filed 2018-08-14 | |||
| 2017-09-30 | $199.76K 10-Q · filed 2017-11-08 | $673.63K derived: sum of 2 quarters · filed 2017-11-08 | $704.75K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $473.87K 10-Q · filed 2017-08-09 | $504.99K 10-Q · filed 2017-08-09 | ||
| 2016-12-31 | $26.82K 10-K · filed 2017-03-15 | |||
| 2016-06-30 | -$3.30K 10-Q · filed 2016-08-09 | |||
| 2015-12-31 | $58.09K 10-K · filed 2017-03-15 | |||
| 2014-12-31 | $1.22K 10-K · filed 2017-03-15 | |||
| 2012-12-31 | $67.30K 10-K · filed 2014-03-07 | |||
| 2011-12-31 | $84.59K 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |